CHEK2 and prostate cancer: For example, in prostate cancer, pathogenic germline variants in DNA repair genes (ATM, CHEK2, PALB2, BRCA2) vary by ancestry; some are enriched or even unique to specific populations, leading to differences in prevalence and risk across groups (25, 26).